Business

DOCM: E-prescription momentum drove double-digit Rx growth and record customer gains in Q3

DOCM: E-prescription momentum drove double-digit Rx growth and record customer gains in Q3

Docmorris LtdOctober 15, 20243
DOCM: E-prescription momentum drove double-digit Rx growth and record customer gains in Q3

About this update from Docmorris Ltd

Rx revenue surged 12.2% year-over-year in Q3, with e-prescriptions driving growth and TeleClinic revenue doubling. Group external revenue rose 4.9% in local currency, and 2024 guidance for 5–10% revenue growth is confirmed. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Docmorris Ltd

More from Docmorris Ltd

All Docmorris Ltd news →